← Open Payments lookup

AMARIS MURRAY: Open Payments

NPI 1841844222 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,276 in 60 payments from 14 companies in 2025. Trend: 2023 $1,622 · 2024 $2,011 · 2025 $1,276

Food & beverage: $1,276
CompanyPaymentsAmount
ABBVIE INC.16$204
Otsuka America Pharmaceutical, Inc.7$181
Neurocrine BioSciences, Inc.5$138
Alkermes, Inc.6$131
Lundbeck LLC4$111
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$110
Axsome Therapeutics, Inc.5$100
Vanda Pharmaceuticals Inc.4$99
E.R. Squibb & Sons, L.L.C.3$77
Indivior Inc.1$35

Products named: VRAYLAR, INGREZZA, ABILIFY MAINTENA, REXULTI, ARISTADA, CAPLYTA, Auvelity, HETLIOZ.

Industry payments across MD — which companies pay providers there.